Earnings Call · Q1 FY2021·2021-05-10

Q1 21EPS -100.00%*·Rev n/aQ4 20EPS -47.83%·Rev n/aQ3 20EPS -2.94%·Rev n/aQ2 20EPS +100.00%*·Rev n/a⚠ consensus missing

Coherus Oncology, Inc. CHRS

McDavid Stilwell — Chief Financial Officer

Dennis Lanfear — Chief Executive Officer

Paul Reider — Chief Commercial Officer

Shah Rahimian — Chief Medical Officer

−0.3%1d on move date3d−3.3%5d+5.7%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CHRS calls or request research access.

More CHRS calls Browse calls Request research access